Age-related macular degeneration (AMD)

We have wide ranging programmes of research in AMD. 

We undertake clinical trials of new treatments such as the GMAN trial (evaluating different treatment regimes using bevacizumab) and trials of dietary supplements through to laboratory-based research into the underlying molecular mechanisms, especially the role of complement factor H and factor H related proteins in AMD pathogenesis.